Exclusive

Publication

Byline

Singapore Clinical Trial: A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder

Singapore, Sept. 6 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More


Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, Sept. 6 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More


Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, Sept. 6 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More


Singapore Clinical Trial: A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors, including Participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Tumors

Singapore, Sept. 6 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembr... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension (PALM-PAH)

Singapore, Sept. 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Eval... Read More


Crime Branch nabs elder who tried to buy justice in tribal girl's death

Jammu, Sept. 6 -- A conspiracy of silence that shadowed one of Jammu and Kashmir's most horrifying crimes has begun to unravel, as the Crime Branch on Sunday arrested an 85-year-old self-styled "commu... Read More


MP Ruhullah accuses GMC Principals of coercing interns to end stir

Srinagar, Sept. 6 -- Srinagar Lok Sabha MP Ruhullah Mehdi on Sunday criticised the Jammu and Kashmir government over the handling of the ongoing protest by medical interns seeking an enhanced stipend,... Read More


Georgina makes bold red carpet appearance at Venice Film FestivalPublished on: September 6, 2026 10:04 AM

Pakistan, Sept. 6 -- Georgina Rodriguez made a show stopping entrance as she walked the red carpet in style at the Venice Film Festival on Friday. What caught fans' attention was her decision not to ... Read More


Allied & healthcare college to come up at Hamirpur

Dharamshala, Sept. 6 -- The Himachal Pradesh government has decided to establish an Allied and Healthcare College at Hamirpur, with a total intake of 330 seats across six professional courses. The co... Read More


Chrissy shares rare photo of kids heading back to schoolPublished on: September 6, 2026 10:03 AM

Pakistan, Sept. 6 -- Chrissy Teigen and John Legend's brood is ready to rule the school. The model gave fans a glimpse into her and the "All of Me" singer's kids' first day of school as Luna, 10, Mile... Read More